Shares of Aethlon Medical, Inc. (NASDAQ:AEMD) last traded at $2.40. (NASDAQ:AEMD) performance year to date is -42.86%. The 200 day simple moving average is -37.24%. The 200 SMA is considered a major indicator by market analysts and traders for determining the long-term trend. The price in the market that coincides with the 200 day SMA is recognized as a key support when price moves above the 200 day SMA or resistance when price drops below the same.
Aethlon Medical, Inc. is a development stage medical device company focused on expanding the applications of our Hemopurifier (R) platform technology, which is designed to rapidly reduce the presence of infectious viruses and other toxins from human blood. In this regard, its core focus is the development of therapeutic devices that treat acute viral conditions, chronic viral diseases and pathogens targeted as potential biological warfare agents. The Hemopurifier(R) combines the established scientific principles of affinity chromatography and hemodialysis as a means to mimic the immune system’s response of clearing viruses and toxins from the blood before cell and organ infection can occur. The Hemopurifier(R) cannot cure viral conditions but can prevent virus and toxins from infecting unaffected tissues and cells. The company has completed pre-clinical blood testing of the Hemopurifier(R) to treat HIV and Hepatitis-C, and have completed human safety trials on Hepatitis-C infected patients in India.
Aethlon Medical, Inc. (NASDAQ:AEMD) has been in the buzz for all the right reasons.
The Barchart Technical Opinion rating is a 16% Buy with a Average short term outlook on maintaining the current direction. Longer term, the trend strength is Minimum.
The Exponential Moving Average is similar to a simple moving average but it uses a weighting element that exponentially drops from the recent data point. EMA analysis assesses the short term,5 days and 13 days, intermediate term that is 20 days and long-term 50 days EMA. These EMAs will give bullish indications when moving above trailing EMAs and below the latest price and vice versa. EMA alerts comprise crossovers that is the 5 day EMA crosses below/above the 20 day EMA and EMA convergences, 5 day EMA comparable to 13 day EMA. The long term and short term EMA’s of 1.92 and 2.26 are lower than the current trading price suggesting a bullish pattern in both short term as well as long term. .
The relative strength index is a momentum oscillator that can measure the magnitude of stock price and velocity changes. Momentum is computed as the ratio of plus price changes to negative price changes. The RSI assessment compares the prevailing RSI against oversold (30), overbought (70) and neutral (50) conditions. Alerts will apprise you when stocks retreat from overbought/oversold levels or breakthrough neutral (50). The current RSI is 62.51 suggesting a bullish price action.
Aethlon Medical, Inc. (NASDAQ:AEMD) is all set to report its earnings on Jun 28/a. As per Zack’s analyst scores, Aethlon Medical, Inc. (NASDAQ:AEMD) currently has a mean brokerage rating of . On a scale of 1-5, a rating of 1 or 2 would imply a buy, and a rating of 4 or 5 would indicate a sell recommendation. A rating of 3 would represent a hold on the equity.
As such, while we consider Aethlon Medical, Inc. (NASDAQ:AEMD) represents a enthralling growth story open to several attractive markets, it would be fascinating to see how it works for long-term shareholders.